The global tissue ablation products market is estimated to witness a healthy CAGR during the forecast period 2013 to 2028, according to a report available on Million Insights. Ablation is an advanced medical technique to treat diseases such as cardiac arrhythmias, cancer, and other medical conditions. In this procedure, damaged tissue is removed from the body or destroyed within the body through excessive heat. Eradication of unhealthy tissues helps prevent proliferation of disease.
Rising cases of chronic diseases such as cancer, arrhythmia, and paroxysmal are anticipated to propel market growth. Such diseases are related to infected tissues creating acute pain or irregularities in the functioning of human body parts. Thereby, it is essential to either remove or destroy that diseased tissues through ablation to prevent disease proliferation. Growing adoption of minimally invasive surgeries among patients and surgeons is driving demand for tissue ablation products market.
Minimally invasive surgeries help in reducing after surgery complications and expedite patient’s recovery. In addition, supportive initiatives being taken by manufacturing companies to train healthcare professionals on ablation equipment is driving the market. Moreover, increasing investments by government across various nations to develop healthcare industry will drive the market over the forecast period.
To cater to rising demand for advanced medical equipment, manufacturing companies are investing in R&D activities to develop advanced products. For example, in February 2019, Medtronic got clearance for Accurian radio frequency (RF) ablation system for nerve tissues from U.S. food and drug administration (FDA). The system sends RF signals to targeted nerves for generating heat that can destroy infected tissues. Heat is controlled using advanced computer to protect healthy tissues surrounding infected area.
Based on product type, the market can be categorized into radiofrequency system, microwave system, ultrasonic system, radiation therapy systems, photonic or laser based systems, cryotherapy systems, and others. Radiofrequency and ultrasonic systems are expected to be the most preferred tissue ablation techniques by surgeons. Ultrasonic ablation is a minimally invasive procedure that efficiently kills tumor cells through ultrasound energy. In this procedure, an ablator is inserted into patient’s body through needle to increase temperature and destroy diseased cells.
In terms of application, the market can be classified into aesthetic surgery, general surgery, oncology, gynecology, and others. Oncology segment is expected to account for highest market share. Rising cases of cancer across the globe is driving demand for advanced medical equipment to support oncology. Increasing use of RF ablation technique to destroy tumor without harming surrounding area is driving segment’s growth.
Regional segmentation includes Asia Pacific, Europe, North America, Latin America, and Middle East and Africa. North America is anticipated to dominate the market over the forecast period. This is attributed to increasing number of geriatric population in the region. Elderly people are liable to chronic disorders due to lack of immunity in their body. Rising cases of chronic disease are likely to increase possibility of surgical treatment. This factor is likely to impel demand for advanced medical equipment in the region.
In Asia Pacific, increasing population of developing countries such as India and China is expected to account for significant market share in the coming years. In addition, increasing investments into healthcare infrastructure in both the countries will drive regional growth. Growing prevalence of cancer in India and China is driving demand for advanced surgical equipment in healthcare facilities. Changing preference for minimally invasive surgical procedures over conventional therapeutic techniques for quick relief is stimulating regional market growth.
Some of the leading companies operating in the tissue ablation products market are Medtronic, Abbott Laboratories, Cynosure, Hologic, and Spectranetics. Most companies are adopting business strategies such as mergers and acquisitions to expand their product portfolio. For instance, Medtronic has plans to acquire EPIX technologies and its catheter-based ablation system. The system is used to create scar tissue in the heart to stop electric signals causing irregularities in heartbeats.
Leading players of Tissue Ablation Products including:
• Abbott Laboratories
• Alcon (Novartis)
• Arthrocare (Smith & Nephew)
• Johnson & Johnson
• Biosense Webster
• Ethicon Endosurgery
• DePuy Synthes
• St. Jude Medical
• Varian Medical
Market split by Type, can be divided into:
• Photonic/Laser-based Systems
• Microwave Ablation Systems
• Radiation Therapy Systems
• Cryotherapy Systems
Market split by Application, can be divided into:
• General surgery
• Aesthetic surgery
Market split by Sales Channel, can be divided into:
• Direct Channel
• Distribution Channel
Market segment by Region/Country including:
• North America (United States, Canada and Mexico)
• Europe (Germany, UK, France, Italy, Russia and Spain etc.)
• Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
• South America Brazil, Argentina, Colombia and Chile etc.)
• Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)
Research Support Specialist, USA